$123.35

+3.72 (+3.11%)

Weekly Expected Move ±5.3%

$110 $117 $123 $130 $137

NYSE · Industrials · Engineering & Construction · Tech Score Neutral · Power 62 · $6.3B mcap · 51M float · 1.09% daily turnover · Short 64% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

50.5 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 25.6%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ECG shows a Weak competitive edge (50.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 25.6% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$152

Low

$176

Avg Target

$200

High

Based on 4 analysts since Aug 4, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 4Hold: 2Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$176.00

Analysts4

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-08-20	D.A. Davidson	Kurt Yinger	$102	$168	+66	+34.1%	$125.32
2026-08-13	Cantor Fitzgerald	—	$115	$152	+37	+11.4%	$136.50
2026-08-06	Oppenheimer	Brent Thielman	$180	$200	+20	+38.7%	$144.20
2026-08-06	Guggenheim	—	$160	$184	+24	+30.7%	$140.75
2026-05-08	Stifel Nicolaus	Brian Brophy	$153	$172	+19	+8.6%	$158.42
2026-05-07	Oppenheimer	—	$105	$180	+75	+6.4%	$169.16
2026-04-30	Guggenheim	Joseph Osha	Initiated	$160	—	+19.3%	$134.09
2026-04-20	GLJ Research	Austin Wang	Initiated	$141	—	+9.0%	$129.34
2026-04-15	Stifel Nicolaus	—	$107	$153	+46	+12.7%	$135.77
2026-02-26	Cantor Fitzgerald	Manish Somaiya	$97	$115	+18	-7.0%	$123.60
2026-01-26	Stifel Nicolaus	—	$94	$107	+13	+17.3%	$91.22
2026-01-23	Cantor Fitzgerald	—	Initiated	$97	—	+5.4%	$92.06
2025-11-06	D.A. Davidson	—	$88	$102	+14	+4.7%	$97.45
2025-11-06	Oppenheimer	—	$90	$105	+15	+7.6%	$97.62
2025-10-09	Stifel Nicolaus	—	Initiated	$94	—	+9.3%	$86.03
2025-10-07	Oppenheimer	Ian Zaffino	$80	$90	+10	+10.0%	$81.82
2025-08-14	D.A. Davidson	Brent Thielman	$55	$88	+33	+14.5%	$76.84
2025-01-07	Oppenheimer	Ian Zaffino	Initiated	$80	—	+15.7%	$69.12
2024-11-04	D.A. Davidson	Brent Thielman	Initiated	$55	—	+2.4%	$53.70

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ECG receives an overall rating of B. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).

Rating Change History

Date	From	To
2026-10-01	B+	B
2026-08-05	B	B+
2026-07-27	B+	B
2026-05-05	A-	B+
2026-05-04	B+	A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 71 Grade A

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

100

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ECG scores highest in Safety (100/100) and lowest in Value (28/100). An overall grade of A places ECG among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

7.36

Safe Zone

Piotroski F-Score

7/9

✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓

Beneish M-Score

-2.44

Unlikely Manipulator

Ohlson O-Score

-7.55

Bankruptcy prob: 0.1%

Low Risk

Credit Rating

AA+

Score: 94.6/100

Trend: Improving

Earnings Quality

100/100

OCF/NI: 1.26x

Accruals: -3.8%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ECG scores 7.36, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ECG scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ECG's score of -2.44 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ECG's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ECG receives an estimated rating of AA+ (score: 94.6/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ECG's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

24.82x

PEG

0.47x

P/S

1.48x

P/B

8.15x

P/FCF

33.94x

P/OCF

26.46x

EV/EBITDA

22.93x

EV/Revenue

2.04x

EV/EBIT

24.41x

EV/FCF

34.69x

Earnings Yield

2.99%

FCF Yield

2.95%

Shareholder Yield

0.00%

Graham Number

$41.09

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 24.8x earnings, ECG commands a growth premium. Graham's intrinsic value formula yields $41.09 per share, 200% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.754

NI / EBT

Interest Burden

0.948

EBT / EBIT

EBIT Margin

0.083

EBIT / Rev

Asset Turnover

2.411

Rev / Assets

Equity Multiplier

2.749

Assets / Equity

ROE

39.5%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ECG's ROE of 39.5% is driven by Asset Turnover (2.411), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$191.32

Price/Value

0.87x

Margin of Safety

13.26%

Premium

-13.26%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ECG's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ECG trades at a -13% premium to its adjusted intrinsic value of $191.32, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 24.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 484 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$123.38

Median 1Y

$164.92

5th Pctile

$62.14

95th Pctile

$435.81

Ann. Volatility

62.3%

Analyst Target

$176.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Jeffrey S. Thiede President and CEO	$850,000	$2,014,001	$4,862,601
Thomas D. Nosbusch Executive Vice President and COO	$550,000	$651,570	$2,289,570
Timothy R. Sznewajs Vice President of Corp. Dev. and Strategy	$281,199	$1,013,105	$1,818,120
Maximillian J Marcy Vice President, CFO and Treasurer	$438,000	$518,888	$1,733,738
Paul R. Sanderson Vice President, CLO and Corporate Secretary	$435,000	$377,924	$1,493,724

CEO Pay Ratio

257:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $4,862,601

Avg Employee Cost (SGA/emp): $18,934

Employees: 10,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

10,000

+14.9% YoY

Revenue / Employee

$374,639

Rev: $3,746,387,000

Profit / Employee

$20,177

NI: $201,770,000

SGA / Employee

$18,934

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	8.2%	15.5%	24.1%	31.6%	38.3%	39.0%	39.5%	39.52%
ROA	2.7%	5.2%	8.4%	11.1%	13.4%	13.9%	14.4%	14.38%
ROIC	4.9%	9.3%	15.7%	33.9%	34.5%	28.7%	25.6%	25.62%
ROCE	6.1%	12.2%	20.0%	27.3%	28.9%	30.2%	31.6%	31.56%
Gross Margin	11.4%	11.2%	13.0%	12.6%	11.6%	12.6%	14.9%	14.85%
Operating Margin	6.1%	6.2%	7.9%	7.3%	6.8%	7.5%	9.1%	9.08%
Net Margin	4.5%	4.4%	5.7%	5.8%	5.5%	5.6%	6.8%	6.81%
EBITDA Margin	7.1%	7.1%	8.8%	9.0%	8.6%	8.5%	9.3%	9.31%
FCF Margin	9.1%	3.6%	2.8%	3.9%	2.4%	5.8%	5.9%	5.87%
OCF Margin	10.9%	5.7%	4.6%	5.5%	4.2%	7.4%	7.5%	7.53%
ROIC Economic	snapshot only							23.39%
Cash ROA	snapshot only							15.61%
Cash ROIC	snapshot only							33.43%
CROIC	snapshot only							26.06%
NOPAT Margin	snapshot only							5.77%
Pretax Margin	snapshot only							7.91%
R&D / Revenue	snapshot only							0.00%
SGA / Revenue	snapshot only							5.27%
SBC / Revenue	snapshot only							0.20%

Valuation

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	97.43	26.64	26.18	24.23	21.70	27.05	33.39	24.819
P/S Ratio	4.42	1.19	1.29	1.25	1.17	1.53	1.99	1.476
P/B Ratio	7.95	4.12	6.31	7.65	6.95	8.80	10.99	8.150
P/FCF	48.62	32.87	46.43	32.34	48.64	26.32	33.94	33.939
P/OCF	40.54	21.06	28.15	22.90	27.91	20.60	26.46	26.457
EV/EBITDA	67.36	19.58	18.17	15.32	13.67	17.69	22.93	22.934
EV/Revenue	4.79	1.39	1.41	1.24	1.15	1.54	2.04	2.035
EV/EBIT	77.03	22.29	20.35	17.01	15.05	19.37	24.41	24.407
EV/FCF	52.63	38.17	50.41	31.97	47.92	26.62	34.69	34.688
Earnings Yield	1.0%	3.8%	3.8%	4.1%	4.6%	3.7%	3.0%	2.99%
FCF Yield	2.1%	3.0%	2.2%	3.1%	2.1%	3.8%	2.9%	2.95%
PEG Ratio	snapshot only							0.473
Price/Tangible Book	snapshot only							17.317
EV/OCF	snapshot only							27.040
EV/Gross Profit	snapshot only							15.638
Acquirers Multiple	snapshot only							26.261
Shareholder Yield	snapshot only							0.00%
Graham Number	snapshot only							$41.09

Leverage & Solvency

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	1.79	1.78	1.77	1.76	1.76	1.77	1.59	1.587
Quick Ratio	1.70	1.69	1.69	1.69	1.70	1.71	1.53	1.528
Debt/Equity	0.86	0.78	0.71	0.17	0.17	0.53	0.47	0.471
Net Debt/Equity	0.66	0.67	0.54	-0.09	-0.10	0.10	0.24	0.242
Debt/Assets	0.28	0.27	0.25	0.06	0.06	0.20	0.18	0.177
Debt/EBITDA	6.73	3.21	1.87	0.35	0.33	1.05	0.96	0.962
Net Debt/EBITDA	5.14	2.72	1.43	-0.18	-0.21	0.20	0.50	0.495
Interest Coverage	9.08	9.98	11.77	13.57	15.42	17.04	19.41	19.409
Equity Multiplier	3.05	2.95	2.88	2.83	2.74	2.69	2.66	2.661
Cash Ratio	snapshot only							0.190
Debt Service Coverage	snapshot only							20.656
Cash to Debt	snapshot only							0.485
FCF to Debt	snapshot only							0.688
Defensive Interval	snapshot only							1780.5 days

Efficiency & Turnover

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.59	1.17	1.69	2.15	2.48	2.47	2.41	2.411
Inventory Turnover	15.39	29.69	45.97	64.05	73.97	72.65	71.59	71.589
Receivables Turnover	1.00	2.70	2.70	3.51	4.91	5.80	4.62	4.621
Payables Turnover	4.88	7.72	11.10	14.42	18.07	15.67	15.62	15.625
DSO	364	135	135	104	74	63	79	79.0 days
DIO	24	12	8	6	5	5	5	5.1 days
DPO	75	47	33	25	20	23	23	23.4 days
Cash Conversion Cycle	313	100	110	84	59	45	61	60.7 days
Fixed Asset Turnover	snapshot only							15.550
Operating Cycle	snapshot only							84.1 days
Cash Velocity	snapshot only							24.151
Capital Intensity	snapshot only							0.482

Growth (YoY)

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	—	—	—	—	3.9%	1.5%	70.1%	70.15%
Net Income	—	—	—	—	4.9%	2.1%	1.1%	1.05%
EPS	—	—	—	—	4.8%	2.1%	1.0%	1.05%
FCF	—	—	—	—	30.3%	3.0%	2.6%	2.58%
EBITDA	—	—	—	—	4.8%	2.1%	95.2%	95.25%
Op. Income	—	—	—	—	4.8%	2.0%	95.1%	95.12%
OCF Growth	snapshot only							1.79%
Asset Growth	snapshot only							38.90%
Equity Growth	snapshot only							50.31%
Debt Growth	snapshot only							0.31%
Shares Change	snapshot only							0.22%

Growth Quality

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	—	—	—	—	—	—	—	—
Earnings Stability	—	—	—	—	—	—	—	—
Margin Stability	—	—	—	—	—	—	—	—
Rev. Growth Consistency	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.500
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.500
FCF Positive Streak	0	0	0	0	1	1	1	0
Earnings Persistence	—	—	—	—	—	—	—	—
Earnings Smoothness	—	—	—	—	0.00	0.00	0.31	0.310
ROE Trend	—	—	—	—	—	—	—	—
Gross Margin Trend	—	—	—	—	—	—	—	—
FCF Margin Trend	—	—	—	—	—	—	—	—
Sustainable Growth Rate	8.2%	15.5%	24.1%	31.6%	38.3%	39.0%	39.5%	39.52%
Internal Growth Rate	2.7%	5.5%	9.1%	12.5%	15.4%	16.2%	16.8%	16.80%

Cash Flow Quality

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	2.40	1.26	0.93	1.06	0.78	1.31	1.26	1.262
FCF/OCF	0.83	0.64	0.61	0.71	0.57	0.78	0.78	0.780
FCF/Net Income	snapshot only							0.984
OCF/EBITDA	snapshot only							0.848
CapEx/Revenue	1.8%	2.0%	1.8%	1.6%	1.8%	1.6%	1.7%	1.66%
CapEx/Depreciation	snapshot only							3.098
Accruals Ratio	-0.04	-0.01	0.01	-0.01	0.03	-0.04	-0.04	-0.038
Sloan Accruals	snapshot only							0.028
Cash Flow Adequacy	snapshot only							4.536
Earnings Quality Score	snapshot only							1.000

Dividends & Buybacks

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Div. Increase Streak	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Shareholder Return	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%

DuPont Factors

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.74	0.74	0.73	0.73	0.74	0.75	0.75	0.754
Interest Burden (EBT/EBIT)	0.98	0.98	0.98	0.97	0.96	0.95	0.95	0.948
EBIT Margin	0.06	0.06	0.07	0.07	0.08	0.08	0.08	0.083
Asset Turnover	0.59	1.17	1.69	2.15	2.48	2.47	2.41	2.411
Equity Multiplier	3.05	2.95	2.88	2.83	2.87	2.79	2.75	2.749

Per Share

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$0.67	$1.39	$2.43	$3.54	$3.94	$4.36	$4.97	$4.97
Book Value/Share	$8.27	$9.01	$10.07	$11.21	$12.31	$13.42	$15.10	$15.14
Tangible Book/Share	$5.47	$6.20	$7.26	$8.41	$9.51	$10.62	$9.58	$9.58
Revenue/Share	$14.87	$31.05	$49.08	$68.34	$73.22	$77.30	$83.33	$83.53
FCF/Share	$1.35	$1.13	$1.37	$2.65	$1.76	$4.49	$4.89	$4.90
OCF/Share	$1.62	$1.76	$2.26	$3.74	$3.07	$5.73	$6.27	$6.29
Cash/Share	$1.68	$1.06	$1.66	$2.92	$3.33	$5.73	$3.45	$3.46
EBITDA/Share	$1.06	$2.20	$3.80	$5.53	$6.16	$6.75	$7.40	$7.40
Debt/Share	$7.11	$7.05	$7.10	$1.95	$2.06	$7.08	$7.11	$7.11
Net Debt/Share	$5.43	$5.99	$5.45	$-0.97	$-1.27	$1.35	$3.66	$3.66

Academic Models

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	7.359
Altman Z-Prime	snapshot only							10.845
Piotroski F-Score	4	4	3	4	6	7	7	7
Beneish M-Score	—	—	—	—	-2.29	-2.50	-2.44	-2.438
Ohlson O-Score	snapshot only							-7.546
ROIC (Greenblatt)	snapshot only							43.35%
Net-Net WC	snapshot only							$3.75
EVA	snapshot only							$150027210.95

Credit

Metric	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only							AA+
Credit Score	70.52	71.06	83.43	94.45	95.40	90.95	94.63	94.630
Credit Grade	snapshot only							2
Credit Trend	snapshot only							11.197
Implied Spread (bps)	snapshot only							65.000
Industry Credit Rank	snapshot only							93
Sector Credit Rank	snapshot only							90

ECG NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet